Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies34
  • 7D1.0%
  • 3M12.7%
  • 1Y4.2%
  • YTD12.2%

In the last week, Healthcare has been flat. The past year has been better, since the industry has gained 4.2% in that time. As for the next few years, earnings are expected to grow by 12% per annum.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Jul 2024CHF 604.8bCHF 148.8bCHF 23.4b34.7x25.8x4.1x
Mon, 24 Jun 2024CHF 573.1bCHF 148.7bCHF 22.7b35.8x25.3x3.9x
Wed, 22 May 2024CHF 562.8bCHF 146.2bCHF 22.9b33.5x24.5x3.9x
Fri, 19 Apr 2024CHF 535.1bCHF 145.1bCHF 22.3b34.4x23.9x3.7x
Sun, 17 Mar 2024CHF 534.3bCHF 143.3bCHF 22.1b37.3x24.2x3.7x
Tue, 13 Feb 2024CHF 515.2bCHF 142.4bCHF 22.3b32.6x23.1x3.6x
Thu, 11 Jan 2024CHF 545.7bCHF 151.3bCHF 21.8b27.4x25x3.6x
Sat, 09 Dec 2023CHF 521.5bCHF 153.5bCHF 22.0b25.5x23.7x3.4x
Mon, 06 Nov 2023CHF 501.6bCHF 154.7bCHF 22.1b23.4x22.7x3.2x
Wed, 04 Oct 2023CHF 530.8bCHF 146.3bCHF 21.3b31.7x24.9x3.6x
Fri, 01 Sep 2023CHF 546.2bCHF 144.2bCHF 21.1b29.7x25.9x3.8x
Sun, 30 Jul 2023CHF 558.6bCHF 146.3bCHF 22.5b36.8x24.9x3.8x
Tue, 27 Jun 2023CHF 558.7bCHF 147.1bCHF 22.2b33.8x25.1x3.8x
Thu, 25 May 2023CHF 579.2bCHF 147.7bCHF 22.3b34.4x26x3.9x
Sat, 22 Apr 2023CHF 588.1bCHF 146.4bCHF 22.3b33.9x26.3x4x
Mon, 20 Mar 2023CHF 531.8bCHF 148.4bCHF 22.6b30.8x23.6x3.6x
Wed, 15 Feb 2023CHF 548.1bCHF 147.8bCHF 22.7b32.7x24.1x3.7x
Fri, 13 Jan 2023CHF 563.2bCHF 148.7bCHF 38.1b31x14.8x3.8x
Sun, 11 Dec 2022CHF 575.0bCHF 148.9bCHF 38.2b31.2x15x3.9x
Tue, 08 Nov 2022CHF 575.3bCHF 152.2bCHF 39.4b27.5x14.6x3.8x
Thu, 06 Oct 2022CHF 572.6bCHF 152.4bCHF 40.4b27.3x14.2x3.8x
Sat, 03 Sep 2022CHF 580.7bCHF 151.9bCHF 40.3b25.8x14.4x3.8x
Mon, 01 Aug 2022CHF 599.6bCHF 149.4bCHF 39.5b32.3x15.2x4x
Wed, 29 Jun 2022CHF 582.7bCHF 148.4bCHF 40.3b29.8x14.5x3.9x
Fri, 27 May 2022CHF 615.5bCHF 148.7bCHF 40.3b31.7x15.3x4.1x
Sun, 24 Apr 2022CHF 660.9bCHF 147.7bCHF 39.8b37.3x16.6x4.5x
Tue, 22 Mar 2022CHF 654.6bCHF 145.7bCHF 39.1b36.9x16.7x4.5x
Thu, 17 Feb 2022CHF 636.6bCHF 144.3bCHF 38.9b42.7x16.4x4.4x
Sat, 15 Jan 2022CHF 662.5bCHF 138.8bCHF 25.1b46.4x26.4x4.8x
Mon, 13 Dec 2021CHF 672.7bCHF 139.2bCHF 25.2b44.1x26.7x4.8x
Wed, 10 Nov 2021CHF 693.3bCHF 137.6bCHF 24.9b49.4x27.9x5x
Fri, 08 Oct 2021CHF 671.1bCHF 137.6bCHF 24.3b44.5x27.6x4.9x
Sun, 05 Sep 2021CHF 705.1bCHF 137.4bCHF 24.2b54x29.1x5.1x
Tue, 03 Aug 2021CHF 698.1bCHF 137.4bCHF 24.2b55x28.8x5.1x
Price to Earnings Ratio

28.8x


Total Market Cap: CHF 698.1bTotal Earnings: CHF 24.2bTotal Revenue: CHF 137.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 22x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.8x which is higher than its 3-year average PE of 22.0x.
  • The industry is trading close to its 3-year average PS ratio of 4.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 2.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market-1.02%
Healthcare0.96%
Life Sciences4.39%
Medical Equipment0.92%
Pharma0.58%
Healthcare Services0.28%
Healthtech-5.69%
Biotech-5.82%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 50.0x.
    • Analysts are expecting annual earnings growth of 19.6%, which is higher than its past year's earnings growth of 6.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings growth rate of 6.5% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 6.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 97.453.5%
+CHF 6.6b		8.0%PE22.1x
ROG Roche HoldingCHF 286.002.8%
+CHF 6.0b		6.2%PE21.5x
LONN Lonza GroupCHF 581.0014.5%
+CHF 5.3b		15.1%PE64.2x
ALC AlconCHF 83.003.8%
+CHF 1.5b		12.2%PE44.3x
SDZ Sandoz GroupCHF 35.914.5%
+CHF 657.5m		n/aPE226.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LONN

CHF 581.00

Lonza Group

7D

14.5%

1Y

15.1%

BANB

CHF 78.95

Bachem Holding

7D

-6.0%

1Y

0.6%

GALD

CHF 66.12

Galderma Group

7D

-6.6%

1Y

n/a

SDZ

CHF 35.91

Sandoz Group

7D

4.5%

1Y

n/a

ROG

CHF 286.00

Roche Holding

7D

2.8%

1Y

6.2%

MEDX

CHF 12.38

medmix

7D

-3.9%

1Y

-48.8%

NOVN

CHF 97.45

Novartis

7D

3.5%

1Y

8.0%

MOLN

CHF 5.60

Molecular Partners

7D

-5.6%

1Y

2.0%

KURN

CHF 12.88

Kuros Biosciences

7D

-0.9%

1Y

443.5%

We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

Jul 16
We Think Kuros Biosciences (VTX:KURN) Can Afford To Drive Business Growth

ALC

CHF 83.00

Alcon

7D

3.8%

1Y

12.2%

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Jul 13
A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

YPSN

CHF 402.00

Ypsomed Holding

7D

2.6%

1Y

56.1%

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03
If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

SOON

CHF 267.00

Sonova Holding

7D

1.7%

1Y

10.5%

TECN

CHF 330.60

Tecan Group

7D

5.5%

1Y

-5.2%

SHLTN

CHF 3.75

SHL Telemedicine

7D

-12.2%

1Y

-53.7%

Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

Jun 04
Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher

STMN

CHF 113.40

Straumann Holding

7D

-2.2%

1Y

-20.9%

Is Straumann Holding (VTX:STMN) A Risky Investment?

Jun 04
Is Straumann Holding (VTX:STMN) A Risky Investment?

BSLN

CHF 39.40

Basilea Pharmaceutica

7D

-1.5%

1Y

-8.9%